Mood stabilizers in the treatment of impulsive behavioral dyscontrol in borderline personality disorder: a systematic review

被引：0
|
作者：
Marini, S. [1 ]
Cinosi, E. [1 ]
Acciavatti, T. [1 ]
Lupi, M. [1 ]
Di Iorio, G. [1 ]
Sepede, G. [1 ]
Gambi, F. [1 ]
Martinotti, G. [1 ]
Di Giannantonio, M. [1 ]
机构：
[1] Univ G DAnnunzio, Imaging & Neurosci, Chieti, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
DOUBLE-BLIND; AGGRESSION; TOPIRAMATE;
D O I：
10.1016/S0924-977X(14)71196-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.8.b.015
引用
收藏
页码：S742 / S742
页数：1
相关论文
共 50 条
  • [41] Personality disorder and alcohol treatment outcome: systematic review and meta-analysis
    Newton-Howes, Giles M.
    Foulds, James A.
    Guy, Nicola H.
    Boden, Joseph M.
    Mulder, Roger T.
    BRITISH JOURNAL OF PSYCHIATRY, 2017, 211 (01) : 22 - 30
  • [42] Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
    Kishi, Taro
    Ikuta, Toshikazu
    Matsuda, Yuki
    Sakuma, Kenji
    Okuya, Makoto
    Mishima, Kazuo
    Iwata, Nakao
    MOLECULAR PSYCHIATRY, 2021, 26 (08) : 4146 - 4157
  • [43] Unmet emotional, interpersonal, and treatment needs in patients with borderline personality disorder
    Kantor, Krystof
    Prasko, Jan
    Ociskova, Marie
    Holubova, Michaela
    Nesnidal, Vlastimil
    Vanek, Jakub
    Minarikova, Kamila
    Hodny, Frantisek
    Slepecky, Milos
    Zatkova, Marta
    NEUROENDOCRINOLOGY LETTERS, 2022, 43 (03) : 180 - 197
  • [44] Pharmacological Treatment for Patients with Borderline Personality Disorder: Practice and Study Results
    Schwerthoeffer, D.
    Baeuml, J.
    Rentrop, M.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (08) : 437 - 443
  • [45] Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
    Wiedlocha, Magdalena
    Marcinowicz, Piotr
    Komarnicki, Jan
    Tobiaszewska, Malgorzata
    Debowska, Weronika
    Debowska, Marta
    Szulc, Agata
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [46] The Treatment of Borderline Personality Disorder: Implications of Research on Diagnosis, Etiology, and Outcome
    Paris, Joel
    ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, 2009, 5 : 277 - 290
  • [47] Quetiapine for the treatment of borderline personality disorder; an open-label study
    Perrella, Carmine
    Carrus, Dario
    Costa, Emilia
    Schifano, Fabrizio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (01): : 158 - 163
  • [48] Open-Label Treatment With Olanzapine for Patients With Borderline Personality Disorder
    Zanarini, Mary C.
    Schulz, S. Charles
    Detke, Holland
    Zhao, Fangyi
    Lin, Daniel
    Pritchard, Mary
    Deberdt, Walter
    Fitzmaurice, Garrett
    Corya, Sara
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (03) : 398 - 402
  • [49] Cannabidiol as a Treatment for Mood Disorders: A Systematic Review
    Pinto, Jairo Vinicius
    Saraf, Gayatri
    Frysch, Christian
    Vigo, Daniel
    Keramatian, Kamyar
    Chakrabarty, Trisha
    Lam, Raymond W.
    Kauer-Sant'Anna, Marcia
    Yatham, Lakshmi N.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2020, 65 (04): : 213 - 227
  • [50] Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study
    Bellino, S.
    Paradiso, E.
    Bozzatello, P.
    Bogetto, F.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) : 333 - 339
12345